NCT04590963 2026-03-13
INTERLINK-1
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
Fondazione IRCCS Policlinico San Matteo di Pavia
Groupe Oncologie Radiotherapie Tete et Cou
UNC Lineberger Comprehensive Cancer Center
Thomas Jefferson University